scispace - formally typeset
J

Jenny Karlsson

Researcher at Lund University

Publications -  85
Citations -  2457

Jenny Karlsson is an academic researcher from Lund University. The author has contributed to research in topics: Dopaminergic & Transplantation. The author has an hindex of 24, co-authored 74 publications receiving 2223 citations. Previous affiliations of Jenny Karlsson include University of New Mexico & University of Hawaii at Manoa.

Papers
More filters
Journal ArticleDOI

Activation of human telomerase reverse transcriptase through gene fusion in clear cell sarcoma of the kidney.

TL;DR: In line with TERT expression being driven by active IRX2 regulatory elements, it is concluded that in addition to promoter mutations and epigenetic events, TERT can also be activated in tumors via formation of fusion transcripts.
Journal ArticleDOI

High-fidelity readout scheme for rare-earth solid-state quantum computing

TL;DR: In this article, the authors proposed a high-fidelity readout scheme for a single-instance approach to quantum computing in rare-earth ion-doped crystals, where the readout ions are doped into the material at a much lower concentration than the qubit ions.
Journal ArticleDOI

Arsenic trioxide is highly cytotoxic to small cell lung carcinoma cells

TL;DR: In addition to cell death induction, antiangiogenic induction of differentiation may also be part of the in vivo effect of As2O3 on SCLC growth, as suggested by an increase in neuroendocrine markers in cultured cells.
Journal ArticleDOI

Clear cell sarcoma of the kidney demonstrates an embryonic signature indicative of a primitive nephrogenic origin.

TL;DR: It is suggested that clear cell sarcoma of the kidney arises from a mesodermal cell type that retains the capacity to initiate differentiation towards both nephrons and stroma, but remains locked in a primitive state.
Journal ArticleDOI

Extensive Clonal Branching Shapes the Evolutionary History of High-Risk Pediatric Cancers

TL;DR: Recovering the evolutionary histories of 56 pediatric primary tumors showed that the mutations most influencing relapse risk occur at initiation of clonal expansion in neuroblastoma and rhabdomyosarcoma, whereas in Wilms tumor, they are late events, suggesting some high-risk childhood cancers are born bad, whereas others grow worse over time.